Skip to content

Haemonetics HAE Intangible assets — net

Intangible assets — net at other companies

ICU Medical logo
ICU MedicalICUI
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
ITG
Integer HoldingsITGR
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's intangible assets — net?
Haemonetics (HAE) reported intangible assets — net of $414.25M in Q4 2025.
How has Haemonetics's intangible assets — net changed year-over-year?
Haemonetics's intangible assets — net decreased by 9.7% year-over-year, from $458.87M to $414.25M.
What is the long-term trend for Haemonetics's intangible assets — net?
Over 3 years (2021 to 2025), Haemonetics's intangible assets — net has grown at a 6.9% compound annual growth rate (CAGR), from $365.48M to $446.55M.